Aion Therapeutic Inc

XCNQ:AION (Canada)   Ordinary Shares
C$ 0.01 (0%) Nov 30
At Loss
Market Cap:
C$ 4.83M ($ 3.45M)
Enterprise V:
C$ 7.26M ($ 5.18M)
Volume:
-
Avg Vol (2M):
108.23K
Trade In:

Business Description

Description
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.03
Equity-to-Asset -3.33
Debt-to-Equity -0.62
Debt-to-EBITDA -0.41
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -49.77
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 35.3
3-Year EPS without NRI Growth Rate 69.1
3-Year FCF Growth Rate 57.1

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 24.07
9-Day RSI 32.04
14-Day RSI 37.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.2
Quick Ratio 0.1
Cash Ratio 0.02
Days Inventory 362.82
Days Sales Outstanding 15.78
Days Payable 1863.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -48.8
Shareholder Yield % -17.23

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 44.39
Operating Margin % -167.33
Net Margin % -789.15
FCF Margin % -144.01
ROA % -381.77
ROIC % -47.9
ROC (Joel Greenblatt) % -3674.85

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 5
EV-to-EBIT -1.18
EV-to-EBITDA -1.19
EV-to-Revenue 9.05
EV-to-FCF -10.47
Earnings Yield (Greenblatt) % -84.57
FCF Yield % -23.88

Financials

XCNQ:AION's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Aion Therapeutic Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0.802
EPS (TTM) (C$) -0.016
Beta -0.19
Volatility % 136.52
14-Day RSI 37.29
14-Day ATR (C$) 0.002541
20-Day SMA (C$) 0.017
12-1 Month Momentum % 0
52-Week Range (C$) 0.005 - 0.02
Shares Outstanding (Mil) 483.55

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aion Therapeutic Inc Filings

Filing Date Document Date Form
No Filing Data

Aion Therapeutic Inc Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Aion Therapeutic Inc Frequently Asked Questions

What is Aion Therapeutic Inc(XCNQ:AION)'s stock price today?
The current price of XCNQ:AION is C$0.01. The 52 week high of XCNQ:AION is C$0.02 and 52 week low is C$0.01.
When is next earnings date of Aion Therapeutic Inc(XCNQ:AION)?
The next earnings date of Aion Therapeutic Inc(XCNQ:AION) is .
Does Aion Therapeutic Inc(XCNQ:AION) pay dividends? If so, how much?
Aion Therapeutic Inc(XCNQ:AION) does not pay dividend.

Press Release

Subject Date
No Press Release